These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22452128)

  • 21. [Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
    Coca A; Ruilope LM
    Med Clin (Barc); 2000 Jul; 115(5):178-80. PubMed ID: 10996874
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
    Weber MA; Giles TD
    Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version].
    Marín R; Goicoechea MA; Gorostidi M; Cases A; Díez J; Escolar G; Fernández-Vega F; Palomar R; Rodrigo E; Martínez I; Segura J;
    Nefrologia; 2006; 26(1):31-44. PubMed ID: 16649424
    [No Abstract]   [Full Text] [Related]  

  • 25. [The clinical pharmacology of hypotensive agents. Angiotensin-converting enzyme inhibitors].
    Chekman IS
    Lik Sprava; 1998 Jun; (4):22-6. PubMed ID: 9784696
    [No Abstract]   [Full Text] [Related]  

  • 26. Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study.
    Ohishi M; Takeya Y; Tatara Y; Yamamoto K; Onishi M; Maekawa Y; Kamide K; Rakugi H
    Hypertens Res; 2010 Nov; 33(11):1150-4. PubMed ID: 20703230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
    Schindler C; Kosa M; Schröder J; Kirch W
    Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385
    [No Abstract]   [Full Text] [Related]  

  • 28. The renin-angiotensin system: a therapeutic target in atrial fibrillation.
    Patlolla V; Alsheikh-Ali AA; Al-Ahmad AM
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):1006-12. PubMed ID: 16981926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hospital intensive monitoring of adverse reactions of ACE inhibitors].
    Mangrella M; Motola G; Russo F; Mazzeo F; Giassa T; Falcone G; Rossi F; D'Alessio O; Rossi F
    Minerva Med; 1998 Apr; 89(4):91-7. PubMed ID: 9676174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P
    Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Angioedema of the mucous membranes of the upper aerodigestive tract after administration of ACE inhibitors].
    Tisch M; Maier H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Feb; 32(2):122-3. PubMed ID: 9172718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a future for direct renin inhibitors?
    Chaudhary K; Nistala R; Whaley-Connell A
    Expert Opin Investig Drugs; 2010 May; 19(5):653-61. PubMed ID: 20380486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cilazapril replacing captopril in the therapy of medium-severe essential hypertension].
    Kovács P; Juhász A; Gábeli T; Karányi Z; Polgár P; Paragh G; Lörincz I; Arnold C
    Orv Hetil; 1995 Oct; 136(42):2273-8. PubMed ID: 7478470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of dual Renin Angiotensin aldosterone system blockade for the treatment of cardiovascular diseases.
    Chrysant SG
    Am J Cardiol; 2010 Mar; 105(6):849-52. PubMed ID: 20211330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond ONTARGET: angiotensin-converting enzyme inhibition and angiotensin II receptor blockade in combination, a lesser evil in some?
    Wong J; Molyneaux L; Constantino M; Twigg SM; Yue DK
    Diabetes Obes Metab; 2010 Dec; 12(12):1072-8. PubMed ID: 20977578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2).
    Lip GY; Beevers DG
    J Hum Hypertens; 2003 Nov; 17(11):747-50. PubMed ID: 14578913
    [No Abstract]   [Full Text] [Related]  

  • 37. Captopril.
    Ram CV
    Arch Intern Med; 1982 May; 142(5):914-6. PubMed ID: 6282230
    [No Abstract]   [Full Text] [Related]  

  • 38. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
    Ram CV
    Future Cardiol; 2009 Sep; 5(5):453-65. PubMed ID: 19715410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.